PE20080537A1 - Derivados de 6-carboxi-normorfinano, su sintesis y usos - Google Patents
Derivados de 6-carboxi-normorfinano, su sintesis y usosInfo
- Publication number
- PE20080537A1 PE20080537A1 PE2007001008A PE2007001008A PE20080537A1 PE 20080537 A1 PE20080537 A1 PE 20080537A1 PE 2007001008 A PE2007001008 A PE 2007001008A PE 2007001008 A PE2007001008 A PE 2007001008A PE 20080537 A1 PE20080537 A1 PE 20080537A1
- Authority
- PE
- Peru
- Prior art keywords
- carboxi
- synthesis
- compound
- normorphinan derivatives
- normorphinan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I EN FORMA DE SAL SELECCIONADA DE BISULFATO, TARTRATO, NITRATO, SULFONATO, FORMIATO, CARBOXILATO, ENTRE OTROS. REFERIDA ADEMAS A UNA COMPOSICION FARMACEUTICA. DICHO COMPUESTO INHIBE LOS EFECTOS SECUNDARIOS DEL TRATAMIENTO DE OPIOIDES TALES COMO INIHIBICION DE LA MOTILIDAD INTESTINAL, DISFUNCION GASTROINTESTINAL, CONSTIPACION, EVACUACION INCOMPLETA, DISTENCION ABDOMINAL, ENTRE OTROS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83568706P | 2006-08-04 | 2006-08-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080537A1 true PE20080537A1 (es) | 2008-06-23 |
Family
ID=38649979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007001008A PE20080537A1 (es) | 2006-08-04 | 2007-08-02 | Derivados de 6-carboxi-normorfinano, su sintesis y usos |
Country Status (15)
Country | Link |
---|---|
US (1) | US7501434B2 (es) |
EP (1) | EP2046800B1 (es) |
JP (1) | JP2009545629A (es) |
CN (1) | CN101522684A (es) |
AR (1) | AR062211A1 (es) |
AT (1) | ATE486076T1 (es) |
AU (1) | AU2007281408A1 (es) |
BR (1) | BRPI0715342A2 (es) |
CA (1) | CA2660027A1 (es) |
CL (1) | CL2007002272A1 (es) |
DE (1) | DE602007010151D1 (es) |
MX (1) | MX2009001282A (es) |
PE (1) | PE20080537A1 (es) |
TW (1) | TW200815451A (es) |
WO (1) | WO2008016704A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030158220A1 (en) * | 1997-11-03 | 2003-08-21 | Foss Joseph F. | Use of methylnaltrexone and related compounds to treat chronic opioid use side effects |
DK2368553T3 (en) | 2003-04-08 | 2015-02-09 | Progenics Pharm Inc | Pharmaceutical preparation comprising methylnaltrexone |
AR057035A1 (es) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS |
AR057325A1 (es) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
TW200817048A (en) * | 2006-09-08 | 2008-04-16 | Wyeth Corp | Dry powder compound formulations and uses thereof |
HUE025662T2 (en) | 2007-03-29 | 2016-04-28 | Wyeth Llc | Peripheral opioid receptor and antagonists and their uses |
CA2865389A1 (en) * | 2007-03-29 | 2008-10-09 | Progenics Pharmaceuticals, Inc. | Crystal forms and uses thereof |
TWI553009B (zh) * | 2007-03-29 | 2016-10-11 | 普吉尼製藥公司 | 末梢性類鴉片受體拮抗劑及其用途 |
EP2240489A1 (en) | 2008-02-06 | 2010-10-20 | Progenics Pharmaceuticals, Inc. | Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone |
CA2719134C (en) * | 2008-03-21 | 2015-06-30 | The University Of Chicago | Treatment with opioid antagonists and mtor inhibitors |
WO2010002576A1 (en) | 2008-07-01 | 2010-01-07 | University Of Chicago | Particles containing an opioid receptor antagonist and methods of use |
CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
WO2015095644A1 (en) | 2013-12-20 | 2015-06-25 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
EP3087057A4 (en) * | 2013-12-26 | 2017-06-28 | Purdue Pharma LP | Ring-contracted morphinans and the use thereof |
CN109096190B (zh) * | 2017-06-21 | 2021-07-02 | 中国医学科学院药物研究所 | 一种青藤碱衍生物及其制备方法、用途和药物组合物 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4176186A (en) * | 1978-07-28 | 1979-11-27 | Boehringer Ingelheim Gmbh | Quaternary derivatives of noroxymorphone which relieve intestinal immobility |
US4719215A (en) | 1986-03-07 | 1988-01-12 | University Of Chicago | Quaternary derivatives of noroxymorphone which relieve nausea and emesis |
US4861781A (en) | 1986-03-07 | 1989-08-29 | The University Of Chicago | Quaternary derivatives of noroxymorphone which relieve nausea and emesis |
US5102887A (en) | 1989-02-17 | 1992-04-07 | Arch Development Corporation | Method for reducing emesis and nausea induced by the administration of an emesis causing agent |
WO1995003308A1 (en) * | 1993-07-23 | 1995-02-02 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
IT1269826B (it) | 1994-05-24 | 1997-04-15 | Paolo Minoia | Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate |
US6559158B1 (en) | 1997-11-03 | 2003-05-06 | Ur Labs, Inc. | Use of methylnaltrexone and related compounds to treat chronic opioid use side affects |
US6274591B1 (en) | 1997-11-03 | 2001-08-14 | Joseph F. Foss | Use of methylnaltrexone and related compounds |
US5972954A (en) | 1997-11-03 | 1999-10-26 | Arch Development Corporation | Use of methylnaltrexone and related compounds |
AU2003290630B2 (en) * | 2002-11-08 | 2009-01-29 | SpecGx LLC | Process for the preparation of quaternary N-alkyl morphinan alkaloid salts |
DK2368553T3 (en) | 2003-04-08 | 2015-02-09 | Progenics Pharm Inc | Pharmaceutical preparation comprising methylnaltrexone |
US8946262B2 (en) | 2003-12-04 | 2015-02-03 | Adolor Corporation | Methods of preventing and treating gastrointestinal dysfunction |
AR057325A1 (es) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
AR057035A1 (es) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS |
TWI489984B (zh) | 2006-08-04 | 2015-07-01 | Wyeth Corp | 用於非經腸道傳輸化合物之配方及其用途 |
TW200817048A (en) | 2006-09-08 | 2008-04-16 | Wyeth Corp | Dry powder compound formulations and uses thereof |
CA2670136A1 (en) | 2006-11-22 | 2008-05-29 | Progenics Pharmaceuticals, Inc. | 7,8-saturated-4,5-epoxy-morphinanium analogs |
US20080234306A1 (en) | 2006-11-22 | 2008-09-25 | Progenics Pharmaceuticals, Inc. | N-Oxides of 4,5-Epoxy-Morphinanium Analogs |
WO2008064150A1 (en) | 2006-11-22 | 2008-05-29 | Progenics Pharmaceuticals, Inc. | Processes for synthesizing quaternary 4,5-epoxy-morphinan analogs and isolating their n-stereoisomers |
HUE025662T2 (en) | 2007-03-29 | 2016-04-28 | Wyeth Llc | Peripheral opioid receptor and antagonists and their uses |
TWI553009B (zh) | 2007-03-29 | 2016-10-11 | 普吉尼製藥公司 | 末梢性類鴉片受體拮抗劑及其用途 |
-
2007
- 2007-07-30 TW TW096127797A patent/TW200815451A/zh unknown
- 2007-08-02 PE PE2007001008A patent/PE20080537A1/es not_active Application Discontinuation
- 2007-08-03 CA CA002660027A patent/CA2660027A1/en not_active Abandoned
- 2007-08-03 CN CNA2007800370327A patent/CN101522684A/zh active Pending
- 2007-08-03 WO PCT/US2007/017365 patent/WO2008016704A1/en active Application Filing
- 2007-08-03 JP JP2009523790A patent/JP2009545629A/ja active Pending
- 2007-08-03 BR BRPI0715342 patent/BRPI0715342A2/pt not_active Application Discontinuation
- 2007-08-03 AU AU2007281408A patent/AU2007281408A1/en not_active Abandoned
- 2007-08-03 EP EP07811067A patent/EP2046800B1/en not_active Not-in-force
- 2007-08-03 AR ARP070103441A patent/AR062211A1/es unknown
- 2007-08-03 US US11/888,955 patent/US7501434B2/en not_active Expired - Fee Related
- 2007-08-03 MX MX2009001282A patent/MX2009001282A/es not_active Application Discontinuation
- 2007-08-03 AT AT07811067T patent/ATE486076T1/de not_active IP Right Cessation
- 2007-08-03 CL CL200702272A patent/CL2007002272A1/es unknown
- 2007-08-03 DE DE602007010151T patent/DE602007010151D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
AR062211A1 (es) | 2008-10-22 |
US20080064744A1 (en) | 2008-03-13 |
US7501434B2 (en) | 2009-03-10 |
BRPI0715342A2 (pt) | 2015-03-24 |
TW200815451A (en) | 2008-04-01 |
MX2009001282A (es) | 2009-02-11 |
DE602007010151D1 (de) | 2010-12-09 |
CL2007002272A1 (es) | 2008-04-18 |
CN101522684A (zh) | 2009-09-02 |
CA2660027A1 (en) | 2008-02-07 |
WO2008016704A1 (en) | 2008-02-07 |
EP2046800B1 (en) | 2010-10-27 |
EP2046800A1 (en) | 2009-04-15 |
JP2009545629A (ja) | 2009-12-24 |
AU2007281408A1 (en) | 2008-02-07 |
ATE486076T1 (de) | 2010-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20080537A1 (es) | Derivados de 6-carboxi-normorfinano, su sintesis y usos | |
PE20090700A1 (es) | Compuestos heterociclicos como antagonistas del receptor opioide periferico | |
AR050952A1 (es) | Derivados de indazolona; procesos para su obtencion; composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta - hsd1. | |
UY30130A1 (es) | Derivados de n-heteroaril-carboxamidas triciclicas que contienen un resto bencimidazol, su preparacion y su aplicacion en terapeutica. | |
ECSP099436A (es) | Acilaminopirazoles como inhibidores de fgfr | |
UY35641A (es) | PROCEDIMIENTO DE SÍNTESIS PARA PREPARAR ANÁLOGOS MACROCÍCLICOS C1-CETO DE HALICONDRINA B, E INTERMEDIARIOS ÚTILES INCLUYENDO INTERMEDIARIOS CONTENIENDO GRUPOS ?SO2-(p-TOLILO) | |
PE20120776A1 (es) | Estructuras cristalinas de dapagliflozin y sus procesos de preparacion | |
UY31127A1 (es) | Ligandos de oxiadazol del receptor metabotropico para el glutamato y su utilizacion como potenciadores - 841 | |
NZ598972A (en) | Spiro-indoline-piperidine derivatives as selective GPR-40 activators for treating diabetes | |
CR11150A (es) | Compuestos de bencimidazol | |
CU24461B1 (es) | Compuestos útiles para tratar envejecimiento prematuro y en particular progeria | |
AR094918A1 (es) | Compuestos de tetrahidropirrolotiazina como inhibidores de bace | |
AR073598A1 (es) | Pirrolidinas 2-carboxamidas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas como agentes anticancer. | |
CR11016A (es) | Compuestos organicos y sus usos | |
PE20120052A1 (es) | Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c][1,2]-oxaborol-1-ol | |
EA201070237A1 (ru) | Четвертичные опиоидные карбоксамиды | |
PE20071143A1 (es) | Composicion farmaceutica que comprende un inhibidor de acetilcolinesterasa y un antagonista 5-hidroxitriptamina-6 | |
PE20120545A1 (es) | Composicion farmaceutica que comprende la forma i cristalina de la sal clorhidrato monohidrato de (5s,8s)-8-[{(1r)-1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diazaspiro[4,5]decan-2-ona | |
IN2012DN00765A (es) | ||
CO6480931A2 (es) | Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas. | |
ECSP10010168A (es) | Benzotiazolas como moduladores del receptor de ghrelina | |
AR090806A1 (es) | Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii | |
MX360330B (es) | Regimen de administracion para nitrocatecoles. | |
DOP2010000317A (es) | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
EA201071352A1 (ru) | Трициклические азотсодержащие соединения и их применение в качестве бактерицидных средств |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FX | Voluntary withdrawal |